Research
Cellular
Research is ongoing to develop improved GLP-1-based therapies, including oral small-molecule agonists and novel drug delivery strategies.
Practitioners should stay informed about emerging GLP-1 therapies that may improve patient compliance.
StrongSupportsmedium confidence
These limitations have driven research into improved GLP-1-based therapies, such as oral small-molecule agonists and novel drug delivery strategies.
Why this rating
The claim is based on a review of ongoing research initiatives.
Source
Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies
Yining Xu et al. · Endocrine Reviews · 2025
DOI 10.1210/endrev/bnaf027
reviewCited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →